Researchers sought to explore the associations between cognitive status, comorbidities, metabolic variables, and lifestyle variables in patients with Parkinson disease from the COPPADIS study.
Researchers sought to analyze the blood pressure (BP) alterations by 24-hour ambulatory BP monitoring in patients with Parkinson disease with different disease stages and subtypes.
In a nationwide register-based cohort study, researchers assessed the prevalence and incidence of Parkinson disease among patients screened for diabetic retinopathy.
Researchers sought to systematically classify loss of balance trends among patients with multiple sclerosis and Parkinson disease.
For patients with Parkinson disease on levodopa therapy, patient-rated quality of life is similar for those receiving adjuvant therapy with dopamine agonists compared with dopamine reuptake inhibitors.
Researchers sought to explore the potential molecular basis for the association between SARS-CoV-2 and the development of Parkinsonism.
Researchers sought to develop a “roadmap” to early intervention and disease prevention for ALS by observing advances in neurodegenerative diseases with a presymptomatic period.
In a cohort study, researchers sought to examine the association of visual impairment with the future risk of developing Parkinson disease.
The fixed-dose combination therapy was found to be superior to each component.
In an update to treatment strategies for motor symptoms in early Parkinson disease, the American Academy of Neurology has reviewed the research on the benefits and risks of available medications.
